Abstract

We disrupted the gene encoding lysophosphatidylinositol-acyltransferase-1 (LPIAT1) in the mouse with the aim of understanding its role in determining cellular phosphoinositide content. LPIAT1−/− mice were born at lower than Mendelian ratios and exhibited a severe developmental brain defect. We compared the phospholipid content of livers and brains from LPIAT1−/− and LPIAT1+/+ littermates by LC-ESI/MS. In accord with previous studies, the most abundant molecular species of each phosphoinositide class (PtdIns, PtdInsP, PtdInsP2 and PtdInsP3) possessed a C38∶4 complement of fatty-acyl esters (C18∶0 and C20∶4 are usually assigned to the sn-1 and sn-2 positions, respectively). LPIAT1−/− liver and brain contained relatively less of the C38∶4 species of PtdIns, PtdInsP and PtdInsP2 (dropping from 95–97% to 75–85% of the total species measured for each lipid class) and relatively more of the less abundant species (PtdInsP3 less abundant species were below our quantification levels). The increases in the less abundant PtdIns and PtdInsP2 species did not compensate for the loss in C38∶4 species, resulting in a 26–44% reduction in total PtdIns and PtdInsP2 levels in both brain and liver. LPIAT1−/− brain and liver also contained increased levels of C18∶0 lyso-PtdIns (300% and 525% respectively) indicating a defect in the reacylation of this molecule. LPIAT1−/− brain additionally contained significantly reduced C38∶4 PC and PE levels (by 47% and 55% respectively), possibly contributing to the phenotype in this organ. The levels of all other molecular species of PC, PE, PS and PA measured in the brain and liver were very similar between LPIAT1−/− and LPIAT1+/+ samples. These results suggest LPIAT1 activity plays a non-redundant role in maintaining physiological levels of PtdIns within an active deacylation/reacylation cycle in mouse tissues. They also suggest that this pathway must act in concert with other, as yet unidentified, mechanisms to achieve the enrichment observed in C38∶4 molecular species of phosphoinositides.

Highlights

  • Individual classes of membrane phospholipids are known to comprise families of molecular species that differ in their fatty acyl composition [1,2]

  • LPIAT12/2 mice were significantly smaller than their littermates (5469.5% of age- and sex-matched WTs) and exhibited a characteristically deformed, domed-shaped head (Figure S1), in addition to an unsteady gait, piloerection, lethargy and difficulties in feeding

  • Western blot analysis with anti-LPIAT1 antibody confirmed that LPIAT12/2 mice expressed no detectable LPIAT1 protein (Figure 1D)

Read more

Summary

Introduction

Individual classes of membrane phospholipids are known to comprise families of molecular species that differ in their fatty acyl composition [1,2]. PtdIns is converted through a series of kinase and phosphatase-catalysed reactions into a series of polyphosphorylated species (PtdIns3P, PtdIns4P, PtdIns5P, PtdIns(3,5)P2, PtdIns(3,4)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3) that are collectively termed phosphoinositides. Most of these polyphosphorylated species have variously well understood functions as molecular signals which regulate membrane events in different cellular locations e.g. trafficking through the endosomal/ lysosomal system, trafficking through the Golgi or delivering proximal cell-surface receptor signalling at the plasma membrane [7]. There is very little data which has measured the fatty acyl complement of the more highly phosphorylated phosphoinositides but the available evidence suggests they are very similar to that of the PtdIns from which they were directly or indirectly synthesised [4,8,9,10], and it is probable that the specific fatty acyl composition of phosphoinositides is related to one or more of their signalling functions

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.